(Q43566977)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Uptake of varicella vaccine--a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Philip Ryan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Don Roberton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

16 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

46-47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

5389-5397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

Varicella-zoster virus infection in Australia

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Parental knowledge, attitudes, and demand regarding a vaccine to prevent varicella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

The effect of vaccination on the epidemiology of varicella zoster virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

The cost-effectiveness of varicella vaccine programs for Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Epidemiologic effects of varicella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

The incidence of shingles and its implications for vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Direct and indirect costs of chickenpox in young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

The cost-effectiveness of routine childhood varicella vaccination in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

The seroepidemiology and transmission dynamics of varicella in Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Varicella serology among school age children with a negative or uncertain history of chickenpox.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

Chickenpox outbreak in a highly vaccinated school population

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

inferred from DOI database lookup

7 January 2021

based on heuristic

Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.033

10.1016/J.VACCINE.2005.05.033

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039020%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference